Antigen-specific immunotherapy in myasthenia gravis: Failed promise and new hope

Journal of Neuroimmunology

Volumn 152, Issue 1-2, 2004, Pages

  Pachner, Andrew R ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIGEN; IMMUNOMODULATING AGENT; NICOTINIC RECEPTOR;

ANTIGEN SPECIFICITY; AUTOIMMUNE DISEASE; EDITORIAL; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOTHERAPY; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; AUTOANTIGENS; HUMANS; IMMUNOTHERAPY; MYASTHENIA GRAVIS; RECEPTORS, CHOLINERGIC;

EID: 3042520983     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.04.016     Document Type: Editorial

References (19)

1. Barchan D., Asher O., Tzartos S.J., Fuchs S., Souroujon M.C. Modulation of the anti-acetylcholine receptor response and experimental autoimmune myasthenia gravis by recombinant fragments of the acetylcholine receptor. Eur. J. Immunol. 28:1998;616-624
2. Bartfeld D., Fuchs S. Specific immunosuppression of experimental autoimmune myasthenia gravis by denatured acetylcholine receptor. Proc. Natl. Acad. Sci. U. S. A. 75:1978;4006-4010
3. Berman P.W., Patrick J. Experimental myasthenia gravis. A murine system. J. Exp. Med. 151:1980;204-223
4. Christadoss P., Poussin M., Deng C. Animal models of myasthenia gravis. Clin. Immunol. 94:2000;75-87
5. Fuchs S., Nevo D., Tarrab-Hazdai R., Yaar I. Strain differences in the autoimmune response of mice to acetylcholine receptors. Nature. 263:1976;329-330
6. Im S.H., Barchan D., Fuchs S., Souroujon M.C. Suppression of ongoing experimental myasthenia by oral treatment with an acetylcholine receptor recombinant fragment. J. Clin. Invest. 104:1999;1723-1730
7. Krolick K.A., Yeh T.M., Edlund S.A. Lewis rats given antibodies against denatured acetylcholine receptor become resistant to induction of experimental autoimmune myasthenia gravis. Cell. Immunol. 172:1996;10-20
8. Lindstrom J., Seybold M., Lennon V. V. Antibody to acetylcholine receptor in myasthenia gravis: prevalence, clinical correlates, and diagnostic value. Neurology. 26:1976;1054-1059
9. Maiti P.K., Feferman T., Im S.-H., Souroujon M.C., Fuchs S. Immunosuppression of rat myasthenia gravis by oral administration of a syngeneic acetylcholine receptor fragment. J. Neuroimmunol. 152:2004;112-120. (this issue)
10. Monfardini C., Milani M., Ostlie N., Wang W., Karachunski P.I., Okita D.K., Lindstrom J., Conti-Fine B.M. Adoptive protection from experimental myasthenia gravis with T cells from mice treated nasally with acetylcholine receptor epitopes. J. Neuroimmunol. 123:2002;123-134
11. Pachner A. Experimental models of myasthenia gravis and their role in devising new therapies for autoimmune disease. Yale J. Biol. Med. 60:1987;169-178
12. Patrick J., Lindstrom J. Autoimmune response to acetylcholine receptor. Science. 180:1973;871
13. Richman D.P., Agius M.A. Treatment of autoimmune myasthenia gravis. Neurology. 61:2003;1652-1661
14. Shenoy M., Oshima M., Atassi M.Z., Christadoss P. Suppression of experimental autoimmune myasthenia gravis by epitope-specific neonatal tolerance to synthetic region alpha 146-162 of acetylcholine receptor. Clin. Immunol. Immunopathol. 66:1993;230-238
15. Sourojon M., Pachner A.R., Fuchs S. The treatment of passively transferred experimental myasthenia with anti-idiotypic antibodies. Neurology. 36:1986;622-625
16. Souroujon M.C., Maiti P.K., Feferman T., Im S.H., Raveh L., Fuchs S. Suppression of myasthenia gravis by antigen-specific mucosal tolerance and modulation of cytokines and costimulatory factors. Ann. N.Y. Acad. Sci. 998:2003;533-536
17. Tarrab-Hazdai R., Aharonov A., Silman I., Fuchs S., Abramsky O. Experimental autoimmune myasthenia induced in monkeys by purified acetylcholine receptor. Nature. 256:1975;128-130
18. Toyka K.V., Drachman D., Pestronk A., Kao I. Myasthenia gravis: passive transfer from man to mouse. Science. 190:1975;397-399
19. Xiao B.G., Duan R.S., Link H., Huang Y.M. Induction of peripheral tolerance to experimental autoimmune myasthenia gravis by acetylcholine receptor-pulsed dendritic cells. Cell. Immunol. 223:2003;63-69